PMID: 11919355Mar 29, 2002Paper

Prescription of antipsychotic drugs by office-based physicians in the United States, 1989-1997

Psychiatric Services : a Journal of the American Psychiatric Association
Richard C HermannMelissa Abraham

Abstract

This study examined trends in the prescription of antipsychotic drugs in a nationally representative sample of physicians in nonfederal office-based clinical practice during the 1990s. The authors analyzed physician-reported data from annual National Ambulatory Medical Care Surveys between 1989 and 1997 using weighted national estimates of physician visits during which antipsychotic drugs were prescribed. Prescription rates for antipsychotic drugs were compared between periods and among demographic, organizational, and clinical subgroups. Prescription of antipsychotic drugs in office-based practice increased significantly between 1989 and 1997. In 1989 antipsychotics were prescribed during 3.2 million office visits (.46 percent of all visits), compared with 6.9 million visits in 1997 (.88 percent). The atypical antipsychotics risperidone and olanzapine were the most widely prescribed antipsychotics in 1997. Risperidone was prescribed during 22.8 percent of all visits that involved prescription of an antipsychotic, and olanzapine during 17.1 percent. Psychiatrists were more likely than other physicians to prescribe an atypical agent (37.1 percent of visits involving prescription of an antipsychotic compared with 14.2 percent). P...Continue Reading

Citations

Apr 3, 2004·Advances in Therapy·Li-Fang Chou
Jan 25, 2005·European Journal of Clinical Pharmacology·Gianluca TrifiròGiampiero Mazzaglia
Jun 23, 2009·Breast Cancer Research and Treatment·Valerie H TaylorSom D Mukherjee
Mar 12, 2011·Current Infectious Disease Reports·Gianluca Trifirò
Jun 28, 2006·International Journal of Obesity : Journal of the International Association for the Study of Obesity·S W KeithD B Allison
Mar 3, 2005·Journal of Child and Adolescent Psychopharmacology·Farifteh Firoozmand DuffyDarrel A Regier
Dec 29, 2005·Journal of Child and Adolescent Psychopharmacology·Smita X AntiaDavid A Baron
Aug 13, 2005·International Clinical Psychopharmacology·Claudia StöllbergerJosef Finsterer
Feb 2, 2010·Clinical Pediatrics·Donna R HalloranMark A Schnitzler
Nov 5, 2013·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·Chintan ShahAnita Kablinger
May 24, 2005·Journal of the American Academy of Child and Adolescent Psychiatry·Nick C PatelPeter S Jensen
Jan 30, 2008·Current Medical Research and Opinion·Elda JanoRajender R Aparasu
Mar 7, 2007·Journal of the American Pharmacists Association : JAPhA·Gordon G LiuZhongyun Zhao
Apr 27, 2010·Pharmacology, Biochemistry, and Behavior·C L Danna, G I Elmer
Feb 5, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Levent AtikIbrahim Balcioglu
Dec 27, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Charles E Dean
Oct 1, 2016·International Journal of Environmental Research and Public Health·Ying-Xiu DaiMing-Hwai Lin
Jan 27, 2004·The Annals of Pharmacotherapy·Gordon G LiuXuemei Luo
Nov 30, 2016·Journal of Medical Ethics·Stijn CleymansChris Bervoets
Nov 10, 2009·International Clinical Psychopharmacology·Gianluca TrifiròFabio Samani
Jun 16, 2005·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Rogelio ApiquianShitij Kapur
Jan 12, 2005·Journal of Clinical Psychopharmacology·Mauro PercudaniLorenzo Petrovich
Dec 10, 2019·Postgraduate Medicine·Amir M MeftahJoshua T Kantrowitz
May 1, 2004·Journal of Clinical Psychopharmacology·Charles E DeanSean M Nugent
Jan 12, 2010·Acta Psychiatrica Scandinavica·H VerdouxB Bégaud
Feb 24, 2006·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Dan CooperJean-Pierre Grégoire
Jan 26, 2006·Annals of Clinical Psychiatry : Official Journal of the American Academy of Clinical Psychiatrists·Rajender R AparasuSanjay Gupta
Apr 12, 2011·CNS Drugs·Thomas R E Barnes, Carol Paton
Jun 15, 2010·Canadian Journal of Psychiatry. Revue Canadienne De Psychiatrie·Valerie TaylorGlenda M Macqueen
Dec 2, 2004·Journal of the American Geriatrics Society·Rosa LiperotiGiovanni Gambassi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.